Current Research Information SysTem In Norway
 
 

 English version


 
Hovedside
Forskningsresultater/NVI
Forskere
Prosjekter
Forskningsenheter
Logg inn
Om Cristin
 
 
   
Eksporter til


Viser treff 1-49 av 49

2015
1 Gimsing, Peter; Hjertner, Øyvind; Abildgaard, Niels; Andersen, Niels Frost; Gedde-Dahl, Tobias Jr.; Gregersen, Henrik Echternach; Klausen, Tobias Wirenfeldt; Mellqvist, Ulf-Henrik; Linder, Olle; Lindås, Roald; Tøffner Clausen, Niels Aage; Lenhoff, Stig.
Salvage bortezomib-dexamethasone and high-dose melphalan (HDM) and autologous stem cell support (ASCT) in myeloma patients at first relapse after HDM with ASCT. A phase-2 trial. Bone Marrow Transplantation 2015 ;Volum 50.(10) s. 1306-1311
HAUKELAND NTNU OUS STO Untitled
 
2013
2 Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav.
Clopidogrel does not work following cardiopulmonary resuscitation. European Journal of Clinical Pharmacology 2013
NTNU STO UIS Untitled
 
3 Mellqvist, Ulf-Henrik; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward; Remes, Kari; Steingrimsdottir, Hlif; Abildgaard, Niels; Ahlberg, Lucia; Blimark, Cecilia; Dahl, Inger Marie; Forsberg, Karin; Gedde-Dahl, Thobias; Gregersen, Henrik; Gruber, Astrid; Gulbrandsen, Nina; Haukås, Einar; Carlson, Kristina; Kvam, Ann Kristin; Nahi, Hareth; Lindås, Roald; Andersen, Niels Frost; Turesson, Ingemar; Waage, Anders; Westin, Jan.
Bortezomib consolidation after autologous stem cell transplantation in multiple myeloma: a Nordic Myeloma Study Group randomized phase 3 trial. Blood 2013 ;Volum 121.(23) s. 4647-4654
HAUKELAND NTNU OUS STO SUS UiT Untitled
 
4 Zeinali, Fatemeh; Fossmark, Reidar; Hauso, Øyvind; Wiseth, Rune; Hjertner, Øyvind; Waldum, Helge.
Serotonin in blood: Assessment of its origin by concomitant determination of beta-thromboglobulin (platelets) and chromogranin A (enterochromaffin cells). Scandinavian Journal of Clinical and Laboratory Investigation 2013 ;Volum 73.(2) s. 148-153
NTNU STO Untitled
 
2012
5 Hjorth, Martin; Hjertner, Øyvind; Knudsen, Lene M; Gulbrandsen, Nina; Holmberg, E; Pedersen, Per Trøllund; Andersen, Niels F; Andreasson, B; Billström, R; Carlson, Kristina; Carlsson, MS; Flogegård, M; Forsberg, Karin; Gimsing, P; Karlsson, T; Linder, Olle; Nahi, Hareth; Othzen, A; Swedin, A.
Thalidomide and dexamethasone vs. bortezomib and dexamethasone for melphalan refractory myeloma: a randomized study. European Journal of Haematology 2012 ;Volum 88.(6) s. 485-496
NTNU OUS STO Untitled
 
2010
6 Waage, Anders; Gimsing, P; Fayers, Peter; Abildgaard, N; Ahlberg, L; Bjorkstrand, B; Carlson, K; Dahl, Inger Marie; Forsberg, K; Gulbrandsen, Nina; Haukås, Einar; Hjertner, Øyvind; Hjorth, M; Karlsson, T; Knudsen, LM; Nielsen, JL; Linder, O; Mellqvist, UH; Nesthus, Ingerid; Rolke, J; Strandberg, M; Sørbø, Jon Hjalmar; Wisløff, Finn; Juliusson, G; Turesson, I.
Melphalan and prednisone plus thalidomide or placebo in elderly patients with multiple myeloma. Blood 2010 ;Volum 116.(9) s. 1405-1412
HAUKELAND HNT NTNU STO SUS UNN OUS UiO Untitled
 
7 Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav.
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Resuscitation 2010 ;Volum 81.(12) s. 1627-1631
NTNU STO SUS Untitled
 
8 Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav.
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Frampeik 2010; 2010-10-22 - 2010-10-24
NTNU SUS Untitled
 
9 Bjelland, Thor Wilhelm; Hjertner, Øyvind; Klepstad, Pål; Kaisen, Kjell; Dale, Ola; Haugen, Bjørn Olav.
Antiplatelet effect of clopidogrel is reduced in patients treated with therapeutic hypothermia after cardiac arrest. Midt-Norsk Kardiologisk Forum; 2010-11-18 - 2010-11-19
NTNU SUS Untitled
 
2009
10 Mellqvist, Ulf-Henrik; Westin, Jan; Gimsing, Peter; Hjertner, Øyvind; Lenhoff, Stig; Laane, Edward; Remes, Kari; Steingrimsdottir, Hlif; Abildgaard, Niels; Ahlberg, Lucia; Carlsson, Kristina; Dahl, Inger Marie S.; Forsberg, Karin; Gedde-dahl, Tobias; Gregersen, Henrik; Gruber, Astrid; Guldbrandsen, Nina; Haukås, Einar; Lindner, Olle; Nahi, Hareth; Nesthus, Ingerid; Toffner-Clausen, Nilsaage; Silvennoinen, Raija; Niels, Frost Andersen; Turesson, Ingemar; Waage, Anders.
Improved Response Rate with Bortezomib Consolidation After High Dose Melphalan: First Results of a Nordic Myeloma Study Group Randomized Phase III Trial. American Society of Hematology; 2009-12-05 - 2009-12-08
HAUKELAND NTNU OUS SUS UiO UNN Untitled
 
11 Hjertner, ¯yvind.
Anbefalinger om behandling av myelomatose. Årsmøte i Norsk Selskap for hematologi; 2009-03-11 - 2009-03-13
NTNU Untitled
 
12 Hjertner, ¯yvind.
Bensykdom ved myelomatose. Årsmøte i Nordisk Myelomatose Studiegruppe; 2009-11-12 - 2009-11-13
NTNU Untitled
 
2007
13 Standal, Therese; Abildgaard, N; Fagerli, Unn-Merete; Stordal, B; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders.
HGF inhibits BMP-induced osteoblastogenesis: possible implications for the bone disease of multiple myeloma. Blood 2007 ;Volum 109.(7) s. 3024-3030
NTNU STO Untitled
 
14 Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Hjertner, ¯yvind; Størdal, Berit Fladvad; Børset, Magne; Sundan, Anders.
Beinsykdommen ved myelomatose. Er HGF skurken?. Norsk Beinsymposium: Osteoporose og beinforskning i Norge; 2007-11-29 - 2007-11-29
NTNU Untitled
 
15 Standal, Therese; Abildgaard, Niels; Fagerli, Unn-Merete; Størdal, Berit Fladvad; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders.
HGF:perpetrator of myeloma bone disease?. Polsk-norsk uke; 2007-10-17 - 2007-10-17
NTNU Untitled
 
2006
16 Hjertner, ¯yvind; Standal, Therese; Børset, Magne; Sundan, Anders; Waage, Anders.
Bone disease in multiple myeloma. Medical Oncology 2006 ;Volum 23.(4) s. 431-441
NTNU STO Untitled
 
17 Standal, Therese; Abildgaard, Niels; Fagerli, Unn-merete; Størdal, Berit Fladvad; Hjertner, Øyvind; Børset, Magne; Sundan, Anders.
HGF Inhibits BMP-Induced Osteoblastogenesis: Implications for the Bone Disease in Multiple Myeloma. Blood 2006 ;Volum 108. s. 3451-
NTNU Untitled
 
2005
18 Hjertner, Øyvind; Standal, Therese; Børset, Magne; Sundan, Anders; Waage, Anders.
Identification of new targets for therapy of osteolytic bone disease in multiple myelomas. Current Drug Targets 2005 ;Volum 6. s. 701-711
NTNU Untitled
 
2004
19 Holt, Randi Utne; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, ¯yvind; Sundan, Anders; Børset, Magne.
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004 ;Volum 23.(17) s. 3024-3032
NTNU Untitled
 
20 Rø, Torstein Baade; Holt, Randi Utne; Brenne, Anne Tove; Hjorth-Hansen, Henrik; Waage, Anders; Hjertner, Øyvind; Sundan, Anders; Børset, Magne.
Bone morphogenetic protein-5, -6 and -7 inhibit growth and induce apoptosis in human myeloma cells. Oncogene 2004 ;Volum 23.(17) s. 3024-32
NTNU Untitled
 
21 Standal, T; Hjorth-Hansen, Henrik; Rasmussen, T; Dahl, Inger Marie S.; Lenhoff, Stig; Brenne, Anne Tove; Seidel, Carina; Baykov, V; Waage, Anders; Børset, Magne; Sundan, Anders; Hjertner, ¯yvind.
Osteopontin is an adhesive factor for myeloma cells and is found in increased levels in plasma from patients with multiple myeloma. Haematologica 2004 ;Volum 89. s. 174-182
NTNU Untitled
 
2003
22 Standal, Therese; Hjorth-Hansen, Henrik; Dahl, Ivar M.; Brenne, Anne Tove; Waage, Anders; Børset, Magne; Sundan, Anders; Hjertner, ¯yvind.
Elevated plasma OPN in multiple myeloma patients. Multiple Myeloma 9th International Workshop; 2003-05-27
NTNU Untitled
 
2002
23 Rø, Torstein Baade; Brenne, Anne Tove; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Sundan, Anders; Waage, Anders; Børset, Magne.
Bone morphogenetic protein-5, -6 and -7 inhibit proliferation and induce apoptosis in four human myeloma cell lines. 18th UICC International Cancer Congress; 2002-07-05
NTNU Untitled
 
24 Rø, Torstein Baade; Holt, Randi Utne; Brenne, Anne Tove; Waage, Anders; Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Sundan, Anders.
Bone Morphogenetic Protein (BMP) Family Members BMP-5, BMP-6 and BMP-7 Inhibit Proliferation and Induce Apoptosis in Human Myeloma cells. American Society of Hematology Forty-fourth annual meeting; 2002-12-10
NTNU Untitled
 
25 Standahl, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Waage, Anders; Børset, Magne; Sundan, Anders.
Osteoprotegerin (OPG) blir bundet, internalisert og degradert av myelomceller. Vintermøte i Norsk selskap for hematologi; 2002-03-22
NTNU Untitled
 
26 Standal, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Waage, Anders; Børset, Magne; Sundan, Anders.
Osteoprotegerin is Bound, Internalized and Degraded by Multiple Myeloma Cells. Blood 2002 ;Volum 100. s. 3002-3007
NTNU Untitled
 
27 Standal, Therese; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Waage, Anders; Børset, Magne; Sundan, Anders.
Osteoprotegerin is bound, internalized and degraded by multiple myeloma cells. 18th UICC International Cancer Congress; 2002-07-05
NTNU Untitled
 
28 Standal, Therese; Waage, Anders; Seidel, Carina; Hjertner, ¯yvind; Plesner, Torben; Sanderson, Ralph D.; Børset, Magne; Sundan, Anders.
Increased clearance of osteoprotegerin (OPG) in multiple myeloma: OPG is internalized and degraded by myeloma cells. Nordisk forening for hematologis vårmøte; 2002-06-01
NTNU Untitled
 
2001
29 Børset, Magne; Standahl, Therese; Hjertner, ¯yvind; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders.
Binding, Internalization and Degradation of Osteoprotegerin in Human Myeloma Cells. American Society of Hematology 43rd Annual Meeting and Exposition; 2001-12-11
NTNU Untitled
 
30 Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders.
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. Blood 2001 ;Volum 97.(2) s. 516-522
NTNU Untitled
 
31 Reseland, Janne E.; Syversen, Unni; Bakke, Ingunn; Qvigstad, G; Eide, Liv G; Hjertner, ¯yvind; Gordeladze, Jan O.; Drevon, Christian A..
Leptin is expressed in and secreted from primary cultures of human osteoblasts and promotes bone mineralization. Journal of Bone and Mineral Research 2001 ;Volum 16. s. 1426-1433
NTNU Untitled
 
32 Seidel, Carina; Hjertner, ¯yvind; Abildgaard, Niels; Heikendorff, Lene; Hjorth, M.; Westin, Jan; Lanng Nielsen, Johan; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders; Børset, Magne.
Serum osteoprotegerin levels are reduced in patients with multiple myeloma with lytic bone disease. Blood 2001 ;Volum 98.(7) s. 2269-2271
NTNU Untitled
 
33 Seidel, Carina; Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Waage, Anders; Sundan, Anders; Børset, Magne; et, al..
OPG levels are reduced in patients with myeloma and correlate with skeletal involvement. Mayo Clinic: The Judith & George Goldman Symposium on Innovative Research in Myeloma; 2001-01-21
NTNU Untitled
 
2000
34 Børset, Magne; Hjertner, ¯yvind; Yaccoby, Shmuel; Epstein, Joshua; Sanderson, Ralph D..
Syndecan-1 is targeted to the uropods of polarized myeloma cells where it promotes adhesion and sequesters heparing-binding proteins. Blood 2000 ;Volum 96. s. 2528-2536
NTNU Untitled
 
35 Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders.
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-second annual meeting; 2000
NTNU Untitled
 
36 Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Børset, Magne; Seidel, Carina; Waage, Anders; Sundan, Anders.
Bone morphogenetic protein-4 inhibits proliferation and induces apoptosis of multiple myeloma cells. American Society of Hematology, Forty-sescond annual Meeting; 2000
NTNU Untitled
 
37 Hjertner, ¯yvind; Qvigstad, Gunnar; Hjorth-Hansen, Henrik; Seidel, Carina; Woodliff, Jeffery; Epstein, Joshua; Waage, Anders; Sundan, Anders; Børset, Magne.
Expression of urokinase plasminogen activator and the urokinase plasminogen activator receptor in myeloma cells. British Journal of Haematology 2000 ;Volum 109. s. 815-822
NTNU Untitled
 
38 Seidel, C; Børset, M; Hjertner, ¯yvind; Cao, D; Abildgaard, N; Hjort Hansen, H; Sanderson, R; Waage, Anders; Sundan, A.
Høye nivåer av løselig syndecan-1 og hepatocyttvekstfaktor (HGF) i beinmark fra myelompasienter: syndecan-1 modulerer biologisk aktivitet av HGF. Nordisk vårmøte i hematologi; 2000
NTNU Untitled
 
39 Seidel, Carina; Børset, Magne; Hjertner, ¯yvind; Cao, Dianjun; Abildgaard, Niels; Hjorth-Hansen, Henrik; Sanderson, Ralph D; Waage, Anders; Sundan, Anders.
High levels of soluble syndecan-1 in myeloma-derived bone marrow : modulation of hepatocyte growth factor activity. Blood 2000 ;Volum 96.(9) s. 3139-3146
NTNU Untitled
 
1999
40 Hjertner, ¯yvind.
Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. The American Society of Hematology 41st Annual Meeting; 1999
NTNU Untitled
 
41 Hjertner, ¯yvind; Hjorth-Hansen, Henrik; Woodliff, J.; Waage, Anders; Børset, Magne.
Expression of urokinase plasminogen activator (uPA) and the uPA receptor (uPAR) in myeloma cells. American Society of Hematology, 41st Annual Meeting,; 1999
NTNU Untitled
 
42 Hjertner, ¯yvind; Lyngaas Torgersen, Maria; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Børset, Magne; Sundan, Anders.
Hepatocyte growth factor (HGF) induces interleukin-11 secretion from osteoblasts: A possible role for HGF in myeloma-associated osteolytic bone disease. Blood 1999 ;Volum 11. s. 3883-3888
NTNU Untitled
 
43 Hjertner, ¯yvind; Torgersen, Maria Lyngaas; Seidel, Carina; Hjort-Hansen, Henrik; Waage, Anders; Børset, Magne; Sundan, Anders.
Hepatocyte Growth Factor (HGF) Induces Interleukin-11 Sedretion From Osteoblasts: A Possible Role for HGF in Myeloma-Associated Osteolytic Bone Disease. Blood 1999 (11) s. 3883-3888
NTNU Untitled
 
44 Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Børset, Magne; Sundan, Anders; Waage, Anders.
Hepatocyte growth factor (HGF) induces interleukin (IL)-6 production in murine osteoblasts, bone marrow stroma and whole organ cultures of calvariae. American Society of Hematology 41st Annual Meeting; 1999
NTNU Untitled
 
45 Hjorth-Hansen, Henrik; Hjertner, ¯yvind; Seidel, Carina; Børset, Magne; Waage, Anders; Sundan, Anders.
Bone morphogenetic protein (BMP)-4 induces apoptosis and inhibits proliferation in myeloma cells by inhibition of the interleukin (IL)-6 signalling pathway. American Society of Hematology 41st Annual Meeting; 1999
NTNU Untitled
 
46 Sundan, Anders; Hjertner, ¯yvind; Torgersen, M. Lyngaas; Seidel, Carina; Hjorth-Hansen, Henrik; Waage, Anders; Børset, Magne.
HGF induces IL-11 secretion from osteoblasts : a possible role for HGFin myeloma-associated bone disease. VII International Multiple Myeloma Workshop; 1999
NTNU Untitled
 
1998
47 Hjertner, ¯yvind; Torgersen, Maria; Hansen, Henrik Hjort; Børset, Magne; Waage, Anders; Sundan, Anders.
A Role for Hepatocyte Growth factor in Myeloma Cell Proliferation and Bone Disease: Induction of IL-6 and IL-11 from Osteoblatsts. The American society for bone and mineral research and the inte rnational bone and mineral society; 1998
NTNU Untitled
 
48 Hjertner, ¯yvind; Torgersen, Maria; Moen, Siv; Børset, Magne; Hjort-Hansen, Henrik; Waage, Anders; Sundan, Anders.
The Expression of hepatocyte growth factor (HGF) and FAS ligands (FAS L) in myeloma cell lines. Biokjemisk kontaktmøte; 1998
NTNU Untitled
 
1996
49 Hjertner, ¯yvind; Børset, Magne; Waage, Anders.
Comparison of the effects of 2-chlorodeoxy-adenosine and melphalan on myeloma cell lines. Leukemia research : a Forum for Studies on Leukemia and Normal Hemopoiesis 1996 ;Volum 20.(2) s. 155-160
NTNU Untitled